BOM Brabant Ventures

As incubator and growth accelerator with over 35 years of experience, BOM Brabant Ventures helps ambitious Brabant companies to grow in a future-proof manner. Through our knowledge and risk capital, we focus on startups and scaleups in Brabant’s top industries: High Tech Systems & Materials Agrofood Biobased Economy Life sciences & Medtech Maintenance Supply chain

19 past transactions

STENTiT

Seed Round in 2022
STENTiT is a medical device spin-off company from the Dutch Eindhoven University of Technology, focusing on the development of regenerative endovascular implants.

Sirius Medical

Series A in 2021
Sirius Medical helps improve healthcare for cancer patients by developing medical devices that aid in surgical treatment. Their objective is to create intuitive and accurate gadgets that allow surgeons and radiologists to provide the finest treatment. Sirius Perception uses audio and visual feedback to provide real-time, directional advice for pinpointing tumors

CtrlChain

Seed Round in 2021
CtrlChain specializes in simplifying and automating logistics management, targeting enhanced profitability, visibility, and service levels for shippers and carriers. Company offers streamlined, centralized systems for managing freight, reducing manual operations and costs, and providing data-driven insights to optimize transport operations.

Scailable

Pre Seed Round in 2021
Scailable is a management platform that allows developers to create plug-and-play edge AI solutions at scale using their artificial intelligence deployment technology. They integrate the AI management platform directly into their CD pipelines to create their own artificial intelligence model management interface.

Orbisk

Seed Round in 2021
Fully automated food waste monitoring. We outfit your waste bin with a scale and a smart camera. The camera runs an AI image recognition algorithm that recognizes ingredients from images. Effortlessly, we register what food is wasted and why. By means of action-oriented dashboarding, you'll be able to find and optimize the inefficiencies in your food-providing process, saving thousands of kilos of food yearly, and improving sustainability and profitability!

Trabotyx

Seed Round in 2021
Trabotyx provides self-weeding. Our wheelbase is adaptable, allowing us to accommodate any field and field layout. The company focuses on weeds near to the plant, which are generally removed by hand. The company concentrates on the 5 centimeter to 1 centimeter area adjacent to the facility. Inter and intra row weeding are both possible. Reduce the necessity for manual labor. The company concentrates on the 5 centimeter to 1 centimeter area adjacent to the facility. Inter and intra row weeding are both possible. reducing the demand for manual labor.

Microsure

Series B in 2021
Microsurgery is characterized by performing surgery close to the limits of what is physically possible. It has designed a motion stabilizer system, which is designed by and for microsurgeons who want to overcome their physical limitations and enhance their performance. The Microsure motion stabilizer system has improved the quality of microsurgical procedures and makes it easier to perform, with the objective to increase the number of treatment options for patients. The extraordinary control and precision offered by the Microsure motion stabilizer provides better and more constant surgical outcome and allows the development of new highly accurate surgical procedures that are currently unavailable. The Microsure system has already been successfully used in a first clinical trial with 8 micro-surgical operations for lymphedema in the Maastricht UMC+. With our investment, Microsure will accelerate the market introduction and sales of its systems. Microsure was founded in 2014 and is headquartered in Eindhoven, The Netherlands.

Shypple

Series A in 2021
Shypple is a digital forwarder for moving freight globally that manages and analyzes supply chains in real-time. Shypple exists of a team of highly motivated “disruptors”, with a background in logistics, international trade, and forwarding. Joint experiences led to a mutual realization: booking, managing, and tracking freight shipments should become faster, easier, and more transparent! Their team’s expertise is strengthened through the data-driven choices that they make. The digital dashboard serves as a central source of information that benefits both Shypple's and the client's logistics team. Without losing the service or personal touch of a good forwarder they ease the logistics of international trade.

Orbisk

Pre Seed Round in 2020
Fully automated food waste monitoring. We outfit your waste bin with a scale and a smart camera. The camera runs an AI image recognition algorithm that recognizes ingredients from images. Effortlessly, we register what food is wasted and why. By means of action-oriented dashboarding, you'll be able to find and optimize the inefficiencies in your food-providing process, saving thousands of kilos of food yearly, and improving sustainability and profitability!

Xyall

Series A in 2020
Xyall is a global innovator in molecular pathology.

Knowingo+

Seed Round in 2019
Knowingo provides live data and statistics on employees’ knowledge levels across different topics.

Citryll

Series A in 2019
Citryll is a private pharmaceutical company that develops pharmaceutical drugs used to treat autoimmune and other human diseases. The company offers formation, function, and clearance of NETs downstream of the protein citrullination pathway catalyzed by Peptidylarginine Deiminase (PAD) enzymes that enable doctors to help in the treatment of lupus, vasculitis, pulmonary fibrosis, rheumatoid arthritis and organ damage due to sepsis. Citryll was established in 2015 and is headquartered in Oss, The Netherlands.

DENS

Seed Round in 2019
Dutch Energy Systems specializes in Hydrozine solutions, which provide hydrogen and electricity to enterprises that run independently of the power grid. DENS solutions aid in the reduction of emissions from heavy-duty vehicles and machinery used in agriculture, construction, and other industries that would otherwise be fueled by diesel.

SamanTree Medical

Series A in 2019
SamanTree Medical is a swiss innovative medical device company providing a breakthrough imaging solution with the potential to improve patient care and cancer surgery outcome. Based on confocal microscopy, SamanTree Medical’s solution brings accurate and full margin control by the surgeon, in the operating room.

Cytosmart

Series B in 2019
Cytosmartb develops smart devices to use in laboratories around the world. It provides CytoSMART Lux2, CytoSMART Exact, and CytoSMART Omni for businesses and individuals. The clients of the company are Fontys, THM, Roche, University of Oxford, EMBL, and University of St Andrews. Cytosmart is a Netherlands-based company that was founded in 2012.

ENPICOM

Series A in 2019
ENPICOM is an innovative bioinformatics software company. They support scientists in biopharma and academic research centers with products and customized solutions to improve and accelerate the discovery and development of novel immunotherapies and vaccines.

Additive Industries

Debt Financing in 2019
Additive Industries is dedicated to bringing metal additive manufacturing for functional parts from lab to fab by offering a modular 3D printing system and seamlessly integrated information platform to high-end and demanding industrial markets. With substantially improved reproducibility, productivity, and flexibility, Additive Industries redefines the business case for additive manufacturing applications in aerospace, automotive, medical technology and high-tech equipment. Additive Industries is lucky to have assembled a true dream team. Highly experienced engineers from the diverse high-tech equipment ecosystem around Eindhoven are complemented with a broad range of other professionals.

DegenRx B.V.

Series A in 2018
DegenRx is a biotech startup working on AAV-mediated gene therapy for CNS disorders like Parkinson's and Alzheimer's. They transmit genes to the brain that start the local synthesis of therapeutic antibodies using adeno-associated-viral vectors. Its goal is to discover and create treatments for neurodegenerative disorders so people can age longer and healthier.

Cytosmart

Series A in 2016
Cytosmartb develops smart devices to use in laboratories around the world. It provides CytoSMART Lux2, CytoSMART Exact, and CytoSMART Omni for businesses and individuals. The clients of the company are Fontys, THM, Roche, University of Oxford, EMBL, and University of St Andrews. Cytosmart is a Netherlands-based company that was founded in 2012.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.